Positron emission tomography as a tool for the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience.
暂无分享,去创建一个
G. Piccoli | C. Fiori | F. Porpiglia | R. Scarpa | V. Consiglio | V. Arena | E. Pelosi | F. Ragni | M. Deagostini | Douroukas Anastasios | G. Cortese
[1] H. Goecke,et al. Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] T. Sauerbruch,et al. Atypical Ormond's disease associated with bile duct stricture mimicking cholangiocarcinoma , 2009, Scandinavian journal of gastroenterology.
[3] A. Vaglio,et al. Images in cardiovascular medicine. Chronic periaortitis. , 2008, Circulation.
[4] M. Stifelman,et al. Robot-assisted ureterolysis, retroperitoneal biopsy, and omental wrap: pilot series for the treatment of idiopathic retroperitoneal fibrosis. , 2008, Journal of endourology.
[5] M. Blake,et al. Retroperitoneal fibrosis: a review of clinical features and imaging findings. , 2008, AJR. American journal of roentgenology.
[6] L. Kavoussi,et al. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. , 2008, The Journal of urology.
[7] K. Farrington,et al. Successful Use of Steroids and Ureteric Stents in 24 Patients with Idiopathic Retroperitoneal Fibrosis: A Retrospective Study , 2008, Nephron Clinical Practice.
[8] M. Stifelman,et al. Minimally invasive management of retroperitoneal fibrosis. , 2008, Urology.
[9] J. Peterson,et al. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases , 2007, Annals of nuclear medicine.
[10] J. Piccini,et al. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. , 2007, The Journal of urology.
[11] S. Jinnouchi,et al. 18F-Fluorodeoxyglucose Positron Emission Tomography Features of Idiopathic Retroperitoneal Fibrosis , 2007, Journal of computer assisted tomography.
[12] R. Clayman,et al. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. , 2007, Urology.
[13] T. Hanslik,et al. Peut-on proposer une prise en charge de la fibrose rétropéritonéale idiopathique validée par les données de la littérature ? , 2006 .
[14] C. Ponticelli,et al. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] D. Tolley,et al. Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment , 2006, BJU international.
[16] T. Hendriksz,et al. Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis , 2006, Annals of Internal Medicine.
[17] D. Grainger,et al. Tamoxifen for the Prevention of Myocardial Infarction in Humans: Preclinical and Early Clinical Evidence , 2005, Circulation.
[18] U. Walker,et al. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature , 2005, Annals of the rheumatic diseases.
[19] D. Salvo,et al. Positron emission tomography (PET): evaluation of chronic periaortitis. , 2005, Arthritis and rheumatism.
[20] A. Vaglio,et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography. , 2005, Clinical and experimental rheumatology.
[21] A. Vaglio,et al. 18F‐fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis , 2005 .
[22] A. Vaglio,et al. Chronic periaortitis: a spectrum of diseases , 2005, Current opinion in rheumatology.
[23] T. MacDonald,et al. Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease , 2004, Annals of Internal Medicine.
[24] P. Bassi,et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. , 2004, The American journal of medicine.
[25] R. Moncayo,et al. Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis? , 2003, Clinical and experimental rheumatology.
[26] H. Myhre,et al. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. , 2003, Journal of vascular surgery.
[27] S. Ferretti,et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. , 2003, The American journal of medicine.
[28] K. Hanash,et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. , 2002, The Journal of urology.
[29] T. Fernández-Villa,et al. Retroperitoneal fibrosis: typical and atypical manifestations. , 2000, The British journal of radiology.
[30] J. Roelandt,et al. Images in Cardiovascular Medicine , 2000 .
[31] H. Suzuki,et al. Retroperitoneal fibrosis and systemic lupus erythematosus. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] C. Ponticelli,et al. Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] G. Gilkeson,et al. RETROPERITONEAL FIBROSIS: A True Connective Tissue Disease , 1996 .
[34] D. Parums. The spectrum of chronic periaortitis , 1990, Histopathology.
[35] M. J. Mitchinson,et al. Chronic periaortitis and periarteritis , 1984, Histopathology.
[36] E. Keystone,et al. The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature. , 1981, The Journal of rheumatology.